Latest
Abatacept May Be Additional Prophylaxis for Graft-vs-Host Disease in Patients With Beta-Thalassemia
Sarclisa Plus Carfilzomib and Dexamethasone Approved for Relapsed/Refractory Multiple Myeloma
More Cases of Blood Clots Linked to AstraZeneca COVID-19 Vaccine
Long-Term Use of BAY 94-9027 Is Safe and Effective in Pediatric Patients With Severe Hemophilia A
COVID-19 Pandemic Has Affected Pediatric Cancer Care Worldwide
Treatment Patterns for Postpartum Hemorrhage Examined
Maintenance Therapy Without Steroids Feasible in Elderly Myeloma Patients
Hemophilia: What Your Patients Need to Know
Daratumumab Not Cost-Effective for Multiple Myeloma
Ixazomib in an Oral Triplet Therapy Shows Benefit for Newly Diagnosed Multiple Myeloma
Abecma Approved for Relapsed/Refractory Multiple Myeloma
Can Premedications, Infusion Rates Be Adjusted Safely With Daratumumab for Multiple Myeloma?
Featured Content
-
Current State and Future Directions for Treating NPM1-Mutated Acute Myeloid Leukemia
Investigators addressed challenges associated with the biology, diagnosis, and current state of treatment for patients with NPM1-mutated AML. -
NCCN Guidelines for Multiple Myeloma Updated to Include Three Selinexor Regimens
The National Comprehensive Cancer Network’s updated Clinical Practice Guidelines in Oncology for multiple myeloma newly include 3 new selinexor-containing regimens. -
Telemedicine for Hematology During COVID-19 and Beyond
The benefits of telemedicine became more evident in the context of the elevated risk of COVID-19 infection and severe symptoms among the patients served by hematology and oncology practices. -
Mild to Moderate Hemophilia: Experts Discuss Challenges and Propose Solutions
A group of US-based hemophilia experts summarized unmet needs in mild to moderate hemophilia and provided suggestions for healthcare professionals to optimally manage their patients with this challenging condition. -
American Society of Hematology Releases Updated Guidelines for Treating Newly Diagnosed AML in Older Adults
This review of the guidelines is presented as 6 questions and answers that help direct treatment decision for patients 65 and older with newly diagnosed AML. -
Clinical Management of Malignant Infantile Osteopetrosis
Investigators discussed their clinical approaches to the diagnosis and management of malignant infantile osteopetrosis, as well as the management of long-term posttrasnplant complications. -
Address Possible Security Lapses as Your Practice Returns to Normal
To accommodate patients remotely during the COVID-19 pandemic, practices may have expanded personnel access to protected health information and relied on devices that might be vulnerable to cyber attacks.
-
Loading...
-
Loading...
